Ishita Roy

Can FDA-approved Journavx Put An End To Death From Opioids?

New painkiller approved

Of the many things <span>FDA</span> approved and banned, the latest on the list is Journavx, a new type of <span>painkiller</span> that does not carry the risk of addiction or overdose associated with opioid medications. This is the first new class of pain medicine approved by the FDA in more than 20 years. 

Jacqueline Corrigan-Curay, the acting director of the FDA's Center for Drug Evaluation and Research in a statement said, "Today’s approval is an important public health milestone in acute pain management. A new non-opioid analgesic therapeutic class for acute pain offers an opportunity to mitigate certain risks associated with using an opioid for pain and provides patients with another treatment option.”

This approval is considered a major breakthrough in treating acute pain without the need for opioid medication as reliance on such medications could lead to addiction. As per the Centers for Disease Control and Prevention (CDC) data, more than 81,000 people in 2023 died in overdoses which involved <span>opioids</span>.

Opioids are used to treat pain, cough, and diarrhea. They can be used to treat pain from an injury, illness or surgery. As per National Institute on Drug Abuse (NIDA), opioids are a class of natural, semi-synthetic, and synthetic drugs. Natural opioids include morphine, codeine, opium and thebaine, semi-synthetic opioids include heroin, oxycodone, hydrocodone, and oxymorphone, whereas synthetic opioids include fentanyl. NIDA also mentions that it can be highly addictive, if misused and can cause breathing difficulties, and overdose could also lead to death. These medications can also cause tolerance, physical dependence and opioid use disorders.

As per the World Health Organization (<span>WHO</span>), the term "opioids" includes compounds that are extracted from the poppy plant as well as semisynthetic and synthetic compounds with similar properties that can interact with opioid receptors in the brain. WHO also notes that in 2019, about 600,000 deaths were causes worldwide due to drug abuse, among them, 80% of the deaths were related to opioids, whereas 25% were caused by opioid overdose. 

What happens when you overdose on opioids:

<ul><li>Pinpoint pupils</li><li>Unconsciousness</li><li>Difficulties with breathing</li></ul>

As per FDA, Journvax "reduces pain by targeting a pain-signaling pathway involving sodium channels in the peripheral nervous system, before pain signals reach the brain." It is different from opioids, as they bind to the receptors in the brain that receive nerve signals from the body. 

The newly approved medicine also showed a "statistically significant superior reduction in pain" when compared to a placebo in two randomized trials, said FDA. However, it did not outperform a common opioid-acetaminophen combination pill.

However, the advantage of the newly approved drug is not its efficacy but the side effect profile, which also includes the absence of addiction potential. The medicine will cost $15.50 per pill, which is more expensive than comparable opioids. 

<h4>Does it have any adverse reaction?</h4>

As per FDA, the common adverse reactions in the study for Journavx, the participants experienced itching, muscle spasms, increased blood level of creatine phosphokinase and rash. 

Health Conditions A-Z

health

FDA approves pain medication

painkiller

pain medicines

opioids

world health organizaition

Love Oranges? Know The Hidden Risks Of Consuming Citrus Fruits

US Reports More Than 2000 COVID-19 Deaths In 28 Days, Why Is It Still A Threat?

Health News

10 Exercises You Can Do While Walking

10 Healthy Savoury Pancakes To Have For Breakfast

10 Herbal Tea Mixes For Winters

10 Habits To Ensure Your Teeth Health

10 Detox Juices You Should Try

10 Low Impact Exercises For Weight Loss

10 Foods That Should Be Part Of A Runners Diet

10 Gym Exercises Basketball Players Should Do

10 Light Foods You Can Eat Before Exercises

10 Ways To Beat The Sleep Spell In Office

10 Tips To Help Muscle Recovery

6-6-6 Walking Routine Can Help You Stay Fit

10 Breathing Exercises To Try When You’re Feeling Anxious

10 Ways To Beat Morning Fatigue

10 Type Of Squats You Can Do For Weight Loss

Soaked vs. Roasted Chickpeas: Which One is Healthier?

10 Ways For Busy People To Stay Active

10 High-Calorie Foods to Watch Out For At Gatherings

10 Brain Exercises to Improve Your Focus and Memory

Creative Ways to Complete Your 10,000 Steps Indoors

10 Best Carb Choices for Managing Type 2 Diabetes

10 White Foods to Avoid for Better Weight Loss Results

10 Delicious Mediterranean Diet Dinners: Low-Carb and High-Protein Options

Healthy and Protein-Packed Late-Night Snacks to Satisfy Your Cravings

10 Negative Habits That Drain Your Mind’s Power

10 Brain-Boosting Activities to Sharpen Your Mind

10 Protein-Rich Breakfast Dishes To Try

10 Signs Your Heart Is Healthy

10 Foods To Improve Your Brain Health

10 Foods That Boost Your Metabolism

10 Exercise To Improve Grip Strength

10 Staple Foods To Make Eating Healthy Easier

10 Foods You Should Eat If You Are Weight-Training

10 Basics Rules Of Weight Training

10 Ways To Deal With Winter Dry Skin

Workout Week: 10 Back Exercises To Do At Gym

10 Healthy Chicken Recipes For Winter

10 Morning Habits That Can Make You Sick

10 Superfood To Help You Build Immunity

10 Cardio Exercises To Lose Belly Fat

Of the many things FDA approved and banned, the latest on the list is Journavx, a new type of painkiller that does not carry the risk of addiction or overdose associated with opioid medications. This is the first new class of pain medicine approved by the FDA in more than 20 years. Jacqueline Corrigan-Curay, the acting director of the FDA's Center for Drug Evaluation and Research in a statement said, "Today’s approval is an important public health milestone in acute pain management. A new non-opioid analgesic therapeutic class for acute pain offers an opportunity to mitigate certain risks associated with using an opioid for pain and provides patients with another treatment option.”Why Is The Approval Important?This approval is considered a major breakthrough in treating acute pain without the need for opioid medication as reliance on such medications could lead to addiction. As per the Centers for Disease Control and Prevention (CDC) data, more than 81,000 people in 2023 died in overdoses which involved opioids.What Are Opioids? Opioids are used to treat pain, cough, and diarrhea. They can be used to treat pain from an injury, illness or surgery. As per National Institute on Drug Abuse (NIDA), opioids are a class of natural, semi-synthetic, and synthetic drugs. Natural opioids include morphine, codeine, opium and thebaine, semi-synthetic opioids include heroin, oxycodone, hydrocodone, and oxymorphone, whereas synthetic opioids include fentanyl. NIDA also mentions that it can be highly addictive, if misused and can cause breathing difficulties, and overdose could also lead to death. These medications can also cause tolerance, physical dependence and opioid use disorders.As per the World Health Organization (WHO), the term "opioids" includes compounds that are extracted from the poppy plant as well as semisynthetic and synthetic compounds with similar properties that can interact with opioid receptors in the brain. WHO also notes that in 2019, about 600,000 deaths were causes worldwide due to drug abuse, among them, 80% of the deaths were related to opioids, whereas 25% were caused by opioid overdose. What happens when you overdose on opioids:Pinpoint pupilsUnconsciousnessDifficulties with breathingJournavx and how it worksAs per FDA, Journvax "reduces pain by targeting a pain-signaling pathway involving sodium channels in the peripheral nervous system, before pain signals reach the brain." It is different from opioids, as they bind to the receptors in the brain that receive nerve signals from the body. The newly approved medicine also showed a "statistically significant superior reduction in pain" when compared to a placebo in two randomized trials, said FDA. However, it did not outperform a common opioid-acetaminophen combination pill.However, the advantage of the newly approved drug is not its efficacy but the side effect profile, which also includes the absence of addiction potential. The medicine will cost $15.50 per pill, which is more expensive than comparable opioids. Does it have any adverse reaction?As per FDA, the common adverse reactions in the study for Journavx, the participants experienced itching, muscle spasms, increased blood level of creatine phosphokinase and rash. 

fda approves pain medication with no risk of addiction or overdose

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

Can FDA-approved Journavx Put An End To Death From Opioids?

US Reports More Than 2000 COVID-19 Deaths In 28 Days, Why Is It Still A Threat?

NBA Star Dwyane Wade Recalls How A Routine Checkup Turned Into Cancer Diagnosis- Know Why Screenings Are Crucial

UK Faces ‘Serious’ TB Outbreak, Health Chief Issues Warning- Here Are Symptoms To Watch For

Health Conditions A-Z

Love Oranges? Know The Hidden Risks Of Consuming Citrus Fruits

Can FDA-approved Journavx Put An End To Death From Opioids?

US Reports More Than 2000 COVID-19 Deaths In 28 Days, Why Is It Still A Threat?